{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:11:03Z","timestamp":1776355863163,"version":"3.51.2"},"reference-count":46,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The trends in metabolic dysfunction-associated steatotic liver disease (MASLD) and related metabolic dysfunctions in Japan are unknown. Thus, we aimed to clarify these trends before the novel coronavirus disease 2019 pandemic in Japan. Materials and Methods: We included Japanese individuals aged 25\u201379 years who underwent health examinations at our center. We analyzed anthropometry, lifestyle-related disease, and nutritional intake in relation to MASLD trends from 2010\u20132019. Results: The prevalence of MASLD increased in all ages and body mass index (BMI) classes, reaching 30.3% in males and 16.1% in females, with MASLD accounting for 75% of steatotic liver cases and more than half of all type 2 diabetes mellitus (T2DM) and high waist circumference (HWC) cases. The increase in the prevalence of MASLD was thought to be largely attributable to an increase in that of the incidence of steatotic liver itself, and there was no increase in the prevalence of other factors, such as overweight, T2DM, hypertension, and dyslipidemia. The prevalence of glucose metabolic disorders (GMDs) and hypertension decreased. National nutritional data showed an increase in energy intake, total fat, saturated fatty acids, monounsaturated fatty acids, and polyunsaturated fatty acids, which correlated with a decrease in GMDs. Salt intake also decreased, which correlated with hypertension. The MASLD group had a higher prevalence of all related metabolic factors than the non-MASLD group, especially HWC, T2DM, and hyperlipidemia. Conclusions: The prevalence of MASLD increased with that of steatotic liver, regardless of age or BMI. A relationship between increased dietary fat, increased steatotic liver, and decreased GMDs was suggested.<\/jats:p>","DOI":"10.3390\/medicina60081330","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T06:23:20Z","timestamp":1723789400000},"page":"1330","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: Prevalence Trends and Clinical Background in the 10 Years before the Coronavirus Disease 2019 Pandemic"],"prefix":"10.3390","volume":"60","author":[{"given":"Akira","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Health Management, St. Marianna University Yokohama Seibu Hospital, 1197-1 Yasashicho Asahi-ku, Yokohama 241-0811, Kanagawa, Japan"},{"name":"Medical Department, Sasaki Foundation Shonan Health Examination Center, 10-4 Takaracho, Hiratsuka 254-0034, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Oomori","sequence":"additional","affiliation":[{"name":"Department of Clinical Examination, Sasaki Foundation Shonan Health Examination Center, 10-4 Takaracho, Hiratsuka 254-0034, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Radiology, Sasaki Foundation Shonan Health Examination Center, 10-4 Takaracho, Hiratsuka 254-0034, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokazu","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Medical Department, Sasaki Foundation Shonan Health Examination Center, 10-4 Takaracho, Hiratsuka 254-0034, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: Definition and subtypes","volume":"29","author":"Han","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Hirose, S., Matsumoto, K., Tatemichi, M., Tsuruya, K., Anzai, K., Arase, Y., Shiraishi, K., Suzuki, M., Ieda, S., and Kagawa, T. (2020). Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0241770"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/CEG.S402498","article-title":"Hypertension and histopathology severity of non-alcoholic fatty liver disease among adults with obesity: A cross-sectional study","volume":"16","author":"Huaman","year":"2023","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.12688\/f1000research.21918.1","article-title":"Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis","volume":"9","year":"2020","journal-title":"F1000Research"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.3350\/cmh.2022.0351","article-title":"Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease","volume":"29","author":"Konyn","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100485","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: Updated naming and diagnosis criteria for fatty liver disease","volume":"65","author":"Rinella","year":"2024","journal-title":"J. Lipid Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00535-012-0533-z","article-title":"Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: A multicenter large retrospective study","volume":"47","author":"Eguchi","year":"2012","journal-title":"J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12072-021-10143-4","article-title":"The epidemiology of NAFLD and lean NAFLD in Japan: A meta-analysis with individual and forecasting analysis, 1995\u20132040","volume":"15","author":"Ito","year":"2021","journal-title":"Hepatol. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00535-003-1178-8","article-title":"Increase in the prevalence of fatty liver in Japan over the past 12 years: Analysis of clinical background","volume":"38","author":"Kojima","year":"2003","journal-title":"J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/hepr.13947","article-title":"Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective study","volume":"53","author":"Fujii","year":"2023","journal-title":"Hepatol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5551\/jat.12.301","article-title":"Metabolic syndrome\u2014Definition and diagnostic criteria in Japan","volume":"12","author":"Matsuzawa","year":"2005","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_13","unstructured":"American Diabetes Association (2024, May 03). Understanding Diabetes Diagnosis. Available online: https:\/\/diabetes.org\/about-diabetes\/diagnosis."},{"key":"ref_14","unstructured":"National Institute of Biomedical Innovation (2024, May 05). Health Japan 21 National Health and Nutrition Survey, Available online: https:\/\/www.nibiohn.go.jp\/eiken\/kenkounippon21\/eiyouchousa\/keinen_henka_eiyou.html."},{"key":"ref_15","unstructured":"Ministry of Health, Labour and Welfare (2024, May 05). FY2019 National Health and Nutrition Survey Report, Available online: https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/kenkou\/eiyou\/r1-houkoku_00002.html."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/ije\/dyv152","article-title":"Data resource profile: The Japan National Health and Nutrition Survey (NHNS)","volume":"44","author":"Ikeda","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation Coefficients: Appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth. Analg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2169\/internalmedicine.1715-23","article-title":"Nonalcoholic fatty liver disease in Japan continue to increase even after the launch of specific health checkups","volume":"63","author":"Sato","year":"2024","journal-title":"Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2169\/internalmedicine.55.6475","article-title":"Increasing number of people with diabetes in Japan: Is this trend real?","volume":"55","author":"Goto","year":"2016","journal-title":"Intern. Med."},{"key":"ref_20","unstructured":"The World Bank (2024, May 05). Diabetes Prevalence\u2014Japan. Available online: https:\/\/data.worldbank.org\/indicator\/SH.STA.DIAB.ZS?end=2021&locations=JP&start=2011."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000335326","article-title":"Evidence-based guideline of the German Nutrition Society: Carbohydrate intake and prevention of nutrition-related diseases","volume":"60","author":"Hauner","year":"2012","journal-title":"Ann. Nutr. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hosseini, F., Jayedi, A., Khan, T.A., and Shab-Bidar, S. (2022). Dietary carbohydrate and the risk of type 2 diabetes: An updated systematic review and dose-response meta-analysis of prospective cohort studies. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-06212-9"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Qi, Y., and Wang, X. (2023). The Role of Gut Microbiota in High-Fat-Diet-Induced Diabetes: Lessons from Animal Models and Humans. Nutrients, 15.","DOI":"10.3390\/nu15040922"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Prasad, M., Rajagopal, P., Devarajan, N., Veeraraghavan, V.P., Palanisamy, C.P., Cui, B., Patil, S., and Jayaraman, S. (2022). A comprehensive review on high -fat diet-induced diabetes mellitus: An epigenetic view. J. Nutr. Biochem., 107.","DOI":"10.1016\/j.jnutbio.2022.109037"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3945\/jn.108.098269","article-title":"Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: Mechanisms of action and implications","volume":"139","author":"Kennedy","year":"2009","journal-title":"J. Nutr."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Neuenschwander, M., Barbaresko, J., Pischke, C.R., Iser, N., Beckhaus, J., Schwingshackl, L., and Schlesinger, S. (2020). Intake of dietary fats and fatty acids and the incidence of type 2 diabetes: A systematic review and dose-response meta-analysis of prospective observational studies. PLoS Med., 17.","DOI":"10.1371\/journal.pmed.1003347"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0140-6736(14)60613-9","article-title":"Prevention and management of type 2 diabetes: Dietary components and nutritional strategies","volume":"383","author":"Ley","year":"2014","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Yaegashi, A., Kimura, T., Wakai, K., Iso, H., and Tamakoshi, A. (J. Epidemiol., 2023). Association between total fat and fatty acid intake and the risk of type 2 diabetes mellitus among Japanese adults: Analysis based on the JACC study, J. Epidemiol., online ahead of print.","DOI":"10.2188\/jea.JE20230076"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.tjnut.2023.03.032","article-title":"Dairy product consumption and incident prediabetes in the Australian Diabetes, Obesity, and Lifestyle Study with 12 years of follow-up","volume":"153","author":"Slurink","year":"2023","journal-title":"J. Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Jiang, S., Yang, W., Li, Y., Feng, J., Miao, J., Shi, H., and Xue, H. (2023). Monounsaturated and polyunsaturated fatty acids concerning prediabetes and type 2 diabetes mellitus risk among participants in the National Health and Nutrition Examination Surveys (NHANES) from 2005 to March 2020. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1284800"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41387-023-00236-4","article-title":"Association between fatty acids and the risk of impaired glucose tolerance and type 2 diabetes mellitus in American adults: NHANES 2005\u22122016","volume":"13","author":"Zhu","year":"2023","journal-title":"Nutr. Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2337\/dc20-2426","article-title":"n-3 Fatty acid biomarkers and incident type 2 diabetes: An individual participant-level pooling project of 20 prospective cohort studies","volume":"44","author":"Qian","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Imamura, F., Micha, R., Wu, J.H.Y., de Oliveira Otto, M.C., Otite, F.O., Abioye, A.I., and Mozaffarian, D. (2016). Effects of saturated fat, polyunsaturated fat, monounsaturated fat, and carbohydrate on glucose-insulin homeostasis: A systematic review and meta-analysis of randomised controlled feeding trials. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002087"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1172\/JCI89444","article-title":"Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance","volume":"127","author":"Kahl","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1210\/jc.2019-00160","article-title":"Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: A randomized trial","volume":"104","author":"Rosqvist","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1210\/jc.2016-3722","article-title":"Randomized controlled trial of a MUFA or fiber-rich diet on hepatic fat in prediabetes","volume":"102","author":"Errazuriz","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","first-page":"87","article-title":"Dietary n-3 and n-6 fatty acid intakes and NAFLD: A cross-sectional study in the United States","volume":"30","author":"Cui","year":"2021","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"Vessby","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: Leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Oniki, K., Saruwatari, J., Izuka, T., Kajiwara, A., Morita, K., Sakata, M., Otake, K., Ogata, Y., and Nakagawa, K. (2015). Influence of the PNPLA3 rs738409 polymorphism on non-alcoholic fatty liver disease and renal function among normal weight subjects. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132640"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kawaguchi, T., Shima, T., Mizuno, M., Mitsumoto, Y., Umemura, A., Kanbara, Y., Tanaka, S., Sumida, Y., Yasui, K., and Takahashi, M. (2018). Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0185490"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Oh, S., Lee, J., Chun, S., Choi, J.-E., Na Kim, M., Chon, Y.E., Ha, Y., Hwang, S.-G., Choi, S.-W., and Hong, K.-W. (2022). Interaction between the PNPLA3 gene and nutritional factors on NAFLD development: The Korean genome and epidemiology study. Nutrients, 15.","DOI":"10.3390\/nu15010152"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00394-018-1675-4","article-title":"Fish intake interacts with TM6SF2 gene variant to affect NAFLD risk: Results of a case\u2013control study","volume":"58","author":"Kalafati","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ortega, \u00c1., Bern\u00e1, G., Rojas, A., Mart\u00edn, F., and Soria, B. (2017). Gene-diet interactions in type 2 diabetes: the chicken and egg debate. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061188"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Hannon, B.A., Khan, N.A., and Teran-Garcia, M. (2018). Nutrigenetic contributions to dyslipidemia: A focus on physiologically relevant pathways of lipid and lipoprotein metabolism. Nutrients, 10.","DOI":"10.3390\/nu10101404"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12199-019-0771-2","article-title":"Gene and environmental interactions according to the components of lifestyle modifications in hypertension guidelines","volume":"24","author":"Kokubo","year":"2019","journal-title":"Environ. Health Prev. Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/8\/1330\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:37:43Z","timestamp":1760110663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/8\/1330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["medicina60081330"],"URL":"https:\/\/doi.org\/10.3390\/medicina60081330","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]}}}